1. Stereotactic Body Radiation Therapy for the Treatment of Primary Cardiac Angiosarcoma Causing Hemodynamic Instability 
Prashant Gabani, MD, Benjamin W. Fischer-Valuck, MD, Clifford G. Robinson, MD, David B. Wilson, MD, PhD, Jeff M. Michalski, MD 
Practical Radiation Oncology 
Volume 9, Issue 1, Pages 5-8 (January 2019)
DOI: /j.prro
Copyright © 2018 American Society for Radiation Oncology Terms and Conditions

2. Figure 1
(A-C) Computed tomography scan of the chest at the time of diagnosis; (D-F) at 6 weeks post-radiation therapy; and (G-I) at 6 months post-radiation therapy. The tumor measured 7.3 cm at the time of diagnosis, which reduced to 5.8 cm after 6 weeks, and 4.1 cm after 6 months. (G) Lung consolidation represented by the red circle is a result of atelectasis and does not represent radiation changes.
Practical Radiation Oncology 2019 9, 5-8DOI: ( /j.prro )
Copyright © 2018 American Society for Radiation Oncology Terms and Conditions

3. Figure 2
Dose distribution in the radiation field using volumetric modulated arc therapy-based treatment plan. Dose is depicted by the colorwash. On the colorwash, the lowest dose is 50% and the highest dose is 135%. Red contour indicates gross tumor volume; green contour indicates internal target volume; and blue contour indicates planning target volume.
Practical Radiation Oncology 2019 9, 5-8DOI: ( /j.prro )
Copyright © 2018 American Society for Radiation Oncology Terms and Conditions